Monday, the U.S. Department of Health and Human Services (HHS) announced that Medicare enrollees will benefit from reduced prices on 54 drugs through Medicare Part B, effective from October 1, 2024, to December 31, 2024.
The program aims to counter drug price hikes that exceed inflation, providing financial relief for over 822,000 Medicare beneficiaries who rely on these medications to treat conditions like cancer, osteoporosis, and pneumonia.
Also Read: Doctors Struggle to Secure Medicare Coverage for Heart Patients on Novo Nordisk’s Wegovy
HHS Secretary Xavier Becerra emphasized that the Biden administration’s prescription drug policies ...